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Abstract Using transient transfection of HEK 293 cells, we 
have studied the activation of Ras, c-Raf, and MAP kinase by 
G protein-coupled receptors, activated G protein a subunit (Ga), 
and 03' subunits (G03'). The expression of constitutively acti- 
vated Gsot, Gia, and G l la  did not have any effect on MAP 
kinase phosphorylation. In contrast, overexpression of G07 
could stimulate the phosphorylation of MAP kinase and enhance 
the MEK kinase activity of c-Raf. Coexpression of dominant 
negative Ras inhibited GOT-induced phosphorylation of MAP 
kinase. Furthermore, the GTP-bound form of Ras was increased 
by overexpression of GOT. These results strongly suggest hat the 
GOT may play an important role in signaling from G protein- 
coupled receptors to the MAP kinase pathway, and the activation 
of Ras and c-Raf may be involved in this signaling cascade in 
HEK 293 cells. 
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1. Introduction 
Mitogen-activated protein kinase (MAP kinase) is involved 
in a variety of cellular signal transduction systems, leading to 
proliferation and differentiation of eukaryotic ells [1,2]. MAP 
kinase, which is also named Erk (extracellular signal-regulated 
kinase), is activated by phosphorylation f both threonine and 
tyrosine residues [3]. This phosphorylation is catalyzed by 
MEK (MAP kinase/Erk inase). MEK is phosphorylated and 
activated by another serine/threonine kinase, Raf [4] or MEK 
kinase (MEKK) [5]. Signaling pathways from growth factor 
receptors to MAP kinases through Ras and Raf have been 
clarified [6]. Growth factor signals are transmitted from recep- 
tors to Ras through the signaling components including intrin- 
sic or associated tyrosine kinases, SH2/SH3 adaptors proteins 
and Ras-guanine nucleotide xchange factors. The GTP-bound 
Ras can associate with Raf to recruit it to the membrane frac- 
tions [7,8]. Raf is subsequently activated by a still unknown 
mechanism, and the activated Raf transmits ignals through a 
protein kinase cascade as described above. 
Heterotrimeric guanine nucleotide-binding proteins (G pro- 
teins), consisting of ~, t ,  and Z subunits, transduce signals from 
seven transmembrane r ceptors to various intracellular effec- 
tors in eukaryotic ells (reviewed in refs. [9,10,11,12]). Agonist 
binding to the receptors induces the dissociation of GDP from 
the ~ subunit, and thereby the binding of GTP to the ~ subunit. 
The GTP-bound ~ subunit acts upon downstream effector mol- 
ecules, including subtypes of adenylyl cyclase, phospholipase C, 
and ion channels. The flZ subunits dissociated from the ~ sub- 
unit also control some effector molecules, including type I and 
type II adenylyl cyclase, phospholipase Cfl, and the inward 
rectifier K + channel. 
Recently, there is accumulating evidence which directs to the 
presence of cross-talks between two major signaling pathways, 
i.e. those involving heterotrimeric G proteins and receptors 
with tyrosine kinases. In Rat-1 cells, lysophosphatidic a id 
(LPA) activates the Ras-MAP kinase pathway through the 
pertussis toxin-sensitive G proteins [13]. Constitutively acti- 
vated Gi2cc, gip2, is oncogenic [14] and elevates the MAP kinase 
activity [15] in the fibroblast cells. On the other hand, cyclic 
AMP inhibits MAP kinase activation through Ras and Raf in 
the same cells [16]. More recently, it has been reported that 
transient expression of G protein flZ subunits (Gflz) stimulates 
the MAP kinase activity in COS cells [17], and coexpression of
dominant negative Ras attenuates its activation [18]. Neverthe- 
less, there is no direct evidence which shows the activation of 
Ras and Raf by Gfly. 
We investigated the mechanism of regulation of the MAP 
kinase pathway by G proteins using transient transfection of 
HEK 293 cells. In this report we show that the overexpression 
of GflZ stimulates MAP kinase through activation of Ras and 
c-Raf. 
2. Materials and methods 
2.1. Cells and transfection 
Human embryonic kidney (HEK) 293 cells were grown at 37°C in 
Dulbecco's modified Eagle's medium (DMEM) supplemented with 
10% fetal calf serum. Transfections were performed using calcium- 
phosphate precipitation. The final amount of transfected DNA for 10 
cm 2 dish was adjusted to 40/2g by adding pCMV5 DNA [19]. 
2.2. Plasmid DNAs 
Complementary DNA coding for the full length Gila was isolated 
from the rat brain cDNA library using human Gil ~ genomic DNA [20] 
as a probe and sequenced. Mouse G1 ls cDNA was cloned by RT-PCR 
as described elsewhere. To make a constitutively activated G protein 
subunit, we substituted a conserved Gin to Leu by site-directed 
mutagenesis. The mutations were confirmed by dideoxynucleotide s - 
quencing. The mutated cDNAs of rat Gila, mouse G1 Is, and bovine 
Gs~ short form [21] were subcloned into the pCMV5 vector. DNAs of 
human wild type, activated mutant Ha-Ras (G 12V) [22], and dominant 
negative Ha-Ras (S 17N) [23] were excised from respective plasmids and 
inserted into pCMV5. Complementary DNAs coding for bovine G 
protein fit [24] and Y2 subunits were provided by M.I. Simon (California 
Institute of Technology) and T. Nukada (Tokyo Institute of Psychia- 
try), respectively, and subcloned into the above xpression vector. Plas- 
mids containing human ml muscarinic acetylcholine r ceptor and m2 
muscarinic acetylcholine r ceptor DNA [25] subcloned into the pCMV 
vector were given by E.M. Ross (University of Texas Southwestern 
Medical Center). Rat secretin receptor cDNA inserted into the CDM8 
vector [26] was a gift from S. Nagata (Osaka Bioscience Institute). 
Mouse fl type PDGF receptor cDNA [27] was also subcloned into 
pCMV5. 
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2.3. MAP kinase mobility shift 
Cells were transfected with the indicated expression plasmids. 
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Twenty four hours after transfection, the cells were serum starved in 
medium containing 1mg/ml bovine serum albumin in DMEM. After 
24 h starvation, the cells were stimulated with agonists for 20 min, and 
lysed on ice with buffer containing 50 mM Hepes, pH 7.0, 150 mM 
NaCI, 10% glycerol, 1% Nonidet P-40, 2 mM MgCI,, 1 mM EDTA, 100 
mM NAP', 10 mM sodium phosphate, 1 mM Na3VO4, 1 mM phen- 
ylmethylsulfonyl fluoride, 20 mM fl-glycerophosphate, 10/.tg,/ml aprot- 
inin, and 1 /zg/ml leupeptin. The lysate was added to 5 x Laemmli 
buffer (0.5 M Tris-HC1, pH 6.8, 10% SDS, 16.6% glycerol, 8.4% 2- 
mercaptoethanol, and 0.5% bromophenol blue) and sonicated. The 
mixture was electrophoresed on 10% SDS-polyacrylamide g l and 
transferred to a nitrocellulose filter. The filter was incubated with Anti- 
MAPK (Erk-2) antibody (UBI), and bands were visualized after treat- 
ment with a peroxidase-labeled s cond antibody by an ECL Detection 
System (Amersham). 
2.4. Raf kinase (MEKK) assay 
Cells were transfected with the indicated expression plasmids to- 
gether with pLNC-Raf-1 :FH6, which was constructed toexpress wild- 
type human c-Raf with flag epitope tag and six histidine residues. One 
day after transfection, cells were starved for 16 h and then stimulated 
with agonists. The medium was removed, and a buffer (20 mM Hepes, 
pH 7.4, 150 mM KCI, 10% glycerol, 0.5% Triton X-100, 5 mM MgCI 2, 
1 mM EDTA, l mM EGTA, 10 mM NaF, 1 mM Na3VO4, 25 mM 
fl-glycerophosphate, 20/tg/ml aprotinin, 10 ¢tg/ml eupeptin, and 10 
¢tg/ml pepstatin A) was added. The cells were scraped off with a rubber 
policeman and harvested by centrifugation. Anti-flag M2 antibody 
(IBI) was mixed with rabbit anti-mouse IgG antiserum (Cappel Labo- 
ratories) and protein A-Sepharose CL-4B (Pharmacia). The cell lysate 
was added to the antibody protein A-Sepharose complex and mixed 
gently at 4°C for 2 h. The precipitate was washed twice with washing 
buffer (50 mM Tris-HCl, pH 7.5, 2 mM MgC12, and 150 mM NaCI) and 
once with kinase buffer (20 mM Hepes, pH 7.3, 5 mM MgCI2, and 0.5 
mM MnCI,). The precipitate was incubated at 30°C for 30 min with 
3.2/~g of the wild-type Xenopus MEK [28], 6.4/lg of the kinase negative 
Xenopus MAP kinase [29], 0.28 mM ATP and 4/tCi [7-32PLATE Re- 
combinant histidine-tagged MEK and GST-kinase deficient MAP ki- 
nase were produced in E. coli and purified as described [28,29]. The 
reaction was stopped by adding 5 x Laemmli buffer and heating at 
95°C for 5 rain. The samples were resolved by 10% SDS-poly- 
acrylamide gel. The radioactivity incorporated into MAP kinase was 
detected by autoradiography and measured by an image analyzer 
(FUJI BAS 2000). 
2.5. Analysis of GDP and GTP bound to Ras 
Cells were transfected with the indicated expression plasmid together 
with l /lg of pCMVc-Ha-Ras containing wild type c-Ha-Ras. After 
serum starvation, HEK 293 cells (6 x l0 t') were labeled for 7 h with 0.5 
mCi/ml [32p]Pi (NEN) in phosphate-free DMEM supplemented with 
1 mg/ml bovine serum albumin and 50/IM Na3VO4. After 5 min stim- 
ulation with or without agonists, the cells were harvested by centrifuga- 
tion. Analysis of guanine nucleotides bound to Ras was performed as 
described [30], 
3. Results 
3.1. Stimulation of MAP kinase phosphorylation 
We transfected HEK 293 cells with several receptors includ- 
ing PDGF, m l muscarinic acetylcholine, m2 muscarinic ace- 
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Fig. 1. Effect of G protein ~ and fly subunits on MAP kinase phospho- 
rylation. Cells were transfected with 10 ,ug of Gsc~-sQ213L DNA, 
Gilc~Q204L DNA, 10,ug of ill DNA and 10,ug of Z2 DNAs, and 10 
/~g of RasG 12V DNA. Two days after transfection, the cell lysates were 
processed as described in section 2. 
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Fig. 2. MAP kinase phosphorylation by cotransfection fG protein fl 
and ?" subunits. Cells were transfected with the indicated amount of ill, 
T2 and Goal DNAs. Two days later, the cell lysates were processed as 
described in section 2. 
tylcholine, and secretin receptors, ml muscarinic, m2 muscar- 
inic, and secretin receptors activate Gq, Gi, and Gs, respec- 
tively. Activation of MAP kinase was assessed by the electro- 
phoretic mobility shift [31]. The relevant agonists caused the 
mobility shifts of the MAP kinase (data not shown). Then we 
tested the possibility whether the transfection of activated mu- 
tants of G protein c~ subunit or ,87 subunit can stimulate the 
phosphorylation of MAP kinase. As shown in Fig. 1, t i lT2 but 
neither the activated mutant of Gsc~ nor Gilc~ could stimulate 
the MAP kinase phosphorylation. Phosphorylation of MAP 
kinase elicited by transfecting an activated Ras (RasG12V) was 
greater than that by fly subunits. Under the same condition, the 
expression of activated G11~ did not affect the phosphoryla- 
tion (data not shown). Transfection with both fl and y subunit 
cDNA was required to show the phosphorylation of MAP 
kinase; neither fl nor 7 subunit cDNA alone being effective 
(Fig. 2). Cotransfection with 1 ¢tg g DNA and fl DNA showed 
MAP kinase phosphorylation. This suggested that small 
amount expression of free fly complex may be sufficient to 
activate MAP kinase. Coexpression of wild type Go~ abolished 
the fly-induced phosphorylation of MAP kinase. These results 
indicate that free Gilt is able to activate the MAP kinase 
pathway. 
3.2. Inhibition of  MAP kinase phosphorylation by dominant 
negative Ras 
To investigate whether G protein-coupled receptors and Gfl)' 
stimulate the MAP kinase pathway either through Ras or inde- 
pendent of Ras, we transfected the dominant negative Ras in 
which Ser 17 was replaced by Asn [32]. Immunoblot analysis 
with anti-Ras antibody (Has 6) indicated the dose-dependent 
expression of the dominant negative Ras (Fig. 3B). The MAP 
kinase phosphorylation i duced by PDGF, secretin, and Gfl7 
was blocked by overexpression of dominant negative Ras. On 
the other hand, the dominant negative mutant did not show any 
inhibitory effect on ml muscarinic receptor-induced phospho- 
rylation. This suggests that the signals from ml receptor do not 
require Ras function for MAP kinase activation in HEK 293 
cells. 
3.3. Activation of  c-Raf kinase activity by fly subunits 
HEK 293 cells were transfected with a cDNA coding for a 
human c-Raf tagged with the flag epitope at its C terminus. The 
c-Raf activity was measured by an immune complex kinase 
assay. The immune complex was incubated with [7-32p]ATP in 
the presence of MEK and kinase-deficient MAP kinase, and the 
incorporation of 32p into the MAP kinase was quantitated. As 
shown in Fig. 4, EGF and carbachol stimulated the MEK 
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Fig. 3. Dominant negative Ras inhibits MAP kinase phosphorylation. I dicated amount of dominant egative Ras (RasS17N) DNA was cotransfected 
with receptors and Gfly DNAs. Two days later, transfected cells were stimulated with 100 ng/ml PDGF, and 100 ,uM carbachol for 20 min. 
(A) Inhibition of MAP kinase phosphorylation. Cell lysates were subjected to immunoblot analysis with anti-Erk2 antibody. (B) Expression of 
dominant negative Ras proteins. Immunoblot analysis was performed with anti-Ras antibody (Has 6) [36]. 
kinase activity of c-Raf. Expression of Gilt  increased the kinase 
activity, although to a lesser extent. 
3.4. Increase of GTP-bound Ras by overexpression f Gilt 
We examined the activation of Ras by G iy  in HEK 293 cells. 
Since we could not obtain the sufficient amount of immune 
precipitates with the endogenous Ras proteins, we transfected 
the cells with the wild type c-Ha-Ras eDNA, the expressed Ras 
proteins were immunoprecipitated by anti-Ras monoclonal n- 
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Fig. 4. Stimulation of Raf kinase activity in 293 cells. Cells were 
cotransfected with indicated plasmids plus wild type c-Raf cDNA. The 
cells were stimulated with 100 ng/ml EGF, or 100pM carbachol for 10 
min. Cell lysates were prepared and c-Raf proteins were immunoprecip- 
itated as described insection 2. The immunoprecipitate was incubated 
with purified recombinant MEK and kinase deficient MAP kinase in 
the presence of[y-32P]ATP at 30°C for 30 min. Radioactivity incorpo- 
rated into MAP kinase was measured by image analyzer. Data are 
shown as the mean _+ S.E. from three to four independent experiments 
(n = 3-4, indicated in parentheses). Asterisks indicate P < 0.01 as com- 
pared with the control value. 
tibody (Y13-259), and the activation of Ras was measured. As 
shown in Fig. 5, overexpression f Gi lt  caused a modest but 
definite increase in the level of Ras" GTP. Treatment with EGF 
increased the ratio of Ras.GTP to Ras. GDP + Ras'GTP by 
2-fold. Carbachol also increased the level of Ras.GTP in the 
cells expressing the m2 muscarinic acetylcholine r ceptor. 
4. Discussion 
In the present study, we examined the activation of Ras, 
c-Raf, and MAP kinase. Overexpression f Gfl?' induced the 
activation of all three molecules, although the activation by 
Gi lt  was not so striking. Transient expression of the activated 
mutants of G protein cz-subunits (Gs~, Gila, and G11~) did not 
show any stimulatory effect on the MAP kinase activation in 
HEK 293 cells. This is consistent with the results from an other 
laboratory using transient transfection of COS cells with an 
epitope-tagged MAP kinase [18]. Crespo et al. [18] indicated 
that the MAP kinase activation by G protein coupled-receptors 
and by overexpression f G ly  was blocked by the dominant 
negative Ras. However, the difference between their results and 
ours is that the ml muscarinic receptor-mediated activation of 
the MAP kinase was inhibited by transfecting dominant nega- 
tive Ras in their case. In contrast, our results uggest that the 
Ras function is not required for the MAP kinase activation 
elicited by the ml muscarinic receptor. In our experiments, ml 
receptor-mediated MAP kinase activation was attenuated by 
prolonged treatment with phorbol ester, which downregulated 
PKC (data not shown). Furthermore, a PKC inhibitor, cal- 
phostin C, had an inhibitory effect on the m 1 receptor-mediated 
MAP kinase activation i  the cells. In HEK 293 cells, it is likely 
that the Gq/Gll-coupled receptor may induce MAP kinase 
activation through the PKC-dependent pathway. In contrast, 
Gly-induced MAP kinase activation appears to be PKC-inde- 
pendent, since the activation by G iy  was insensitive to the 
pretreatment with phorbol ester (data not shown). 
The membrane localization of Gi lt  is necessary for transduc- 
ing the signals to effector molecule(s) because coexpression of
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Fig. 5. Activation of Ras by transfecting G protein fly subunits and agonist stimulation. 293 cells were transfected with the indicated expression 
plasmids plus wild type c-Ha-Ras cDNA. Forty eight hours later, quiescent cells were labeled with [32p]Pi for 7 h and stimulated with 100/tM carbachol 
for 7 rain, and 100 ng/ml EGF for 5 min. After preparation ofcell lysates, Ras proteins were immunoprecipitated with anti-Ras monoclonal ntibody 
(Y13-259). The guanine nucleotides bound to the Ras proteins were resolved using thin layer chromatography. (A) Autoradiograph of GTP and 
GDP bound to Ras on TLC plate. (B) Increase of percent ratio of GTP/(GTP + GDP) by transfecting GflZ and agonist stimulation. Bars show the 
mean _+ S.E. from three to four separate xperiments (n -- 3-4, indicated in parentheses). Asterisks indicate P < 0.01 as compared with the control 
value. 
the isoprenylation-deficient mutant of G Z with wild type Gfl 
failed to activate the MAP kinase pathway [18, and data not 
shown]. Recently, it has been reported that Gfly interacts with 
several polypeptides containing pleckstrin homology (PH) do- 
mains, i.e. f-adrenergic receptor kinase (flARK), Ras-GAP, 
PLCz [33], and Btk [34]. Expression of Gf),-binding polypep- 
tide o f f  ARK showed an inhibitory effect on the activation of 
Ras and MAP kinase induced by G protein-coupled receptor 
[35]. This finding also supports our conclusion that free Gfy  
released from G~ upon receptor activation transduces the sig- 
nal to Ras proteins in the membranes. Demonstration and 
identification of the putative ffector molecule(s) which medi- 
ate the signals from the G protein Ely subunits to Ras activation 
is under investigation. 
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